Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma
Clinical trial NCT00462982 · COMPLETED
Trial details
- NCT number
- NCT00462982
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-08-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.